Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

DANAHER CORPORATION

(DHR)
  Report
Real-time Estimate Cboe BZX  -  03:23 2022-12-07 pm EST
266.38 USD   +0.39%
12/06Danaher Announces Quarterly Dividends
PR
12/06Danaher Corporation Announces Quarterly Dividends, Payable on January 27, 2023
CI
11/30Transcript : Danaher Corporation Presents at 5th Annual Evercore ISI HealthCONx Conference 2022, Nov-30-2022 10:30 AM
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Danaher: 4Q Earnings Snapshot

01/30/2020 | 06:26am EST

WASHINGTON (AP) _ Danaher Corp. (DHR) on Thursday reported fourth-quarter profit of $1.28 billion.

The Washington-based company said it had net income of $1.73 per share. Earnings, adjusted to account for discontinued operations, were $1.28 per share.

The industrial and medical device maker posted revenue of $4.87 billion in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $4.79 billion.

For the year, the company reported profit of $3.01 billion, or $4.05 per share. Revenue was reported as $17.91 billion.

Danaher shares have risen almost 8% since the beginning of the year, while the Standard & Poor's 500 index has increased slightly more than 1%. The stock has risen 57% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DHR at https://www.zacks.com/ap/DHR

Automated Insights, source Associated Press News

All news about DANAHER CORPORATION
12/06Danaher Announces Quarterly Dividends
PR
12/06Danaher Corporation Announces Quarterly Dividends, Payable on January 27, 2023
CI
11/30Transcript : Danaher Corporation Presents at 5th Annual Evercore ISI HealthCO..
CI
11/29Insider Sell: Danaher
MT
11/29Barclays Lowers Price Target on Danaher to $277 From $285, Reiterates Overweight Rating
MT
11/22Danaher to Present at Evercore ISI HealthCONx Conference
PR
11/16Insider Sell: Danaher
MT
11/15Cepheid Launches Multiplex Vaginal Panel (MVP) to Support More Accurate Women's Health ..
PR
11/14Insider Sell: Danaher
MT
11/14Insider Sell: Danaher
MT
More news
Analyst Recommendations on DANAHER CORPORATION
More recommendations
Financials (USD)
Sales 2022 30 808 M - -
Net income 2022 6 592 M - -
Net Debt 2022 12 148 M - -
P/E ratio 2022 30,6x
Yield 2022 0,38%
Capitalization 193 B 193 B -
EV / Sales 2022 6,66x
EV / Sales 2023 6,44x
Nbr of Employees 79 000
Free-Float 74,6%
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 265,35 $
Average target price 305,16 $
Spread / Average Target 15,0%
EPS Revisions
Managers and Directors
Rainer M. Blair President, Chief Executive Officer & Director
Matthew R. McGrew Chief Financial Officer & Executive Vice President
Steven M. Rales Chairman
Jose-Carlos GutiÚrrez-Ramos Chief Science Officer & Senior Vice President
Sadik Kassim Chief Technology Officer
Sector and Competitors